Sarantis Livadas
Overview
Explore the profile of Sarantis Livadas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
916
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angelopoulos N, Paparodis R, Androulakis I, Boniakos A, Livadas S
Nutrients
. 2025 Feb;
17(3).
PMID: 39940277
Background/objectives: Vitamins D and B12 play a crucial role in maintaining bone health, immune function, and neurological integrity. Combined deficiencies in these vitamins can lead to severe health consequences. Current...
2.
Livadas S, Angelopoulos N, Kollias A, Paparodis R, Androulakis I, Anagnostis P, et al.
J Endocrinol Invest
. 2025 Feb;
PMID: 39899246
Purpose: Levothyroxine (LT4) is commonly prescribed, but there is evidence strongly suggesting that a significant proportion of these patients are on treatment without solid evidence of hypothyroidism. Small trials on...
3.
Paparodis R, Bantouna D, Livadas S, Angelopoulos N
Curr Atheroscler Rep
. 2024 Dec;
27(1):21.
PMID: 39738779
Purpose Of Review: Atherosclerotic cardiovascular disease (ASCVD) is one of the most common causes of death globally and the leading one in the US. Elevated low-density lipoprotein (LDL) cholesterol is...
4.
Pililis S, Lampsas S, Kountouri A, Pliouta L, Korakas E, Livadas S, et al.
Medicina (Kaunas)
. 2024 Oct;
60(10).
PMID: 39459443
Polycystic Ovarian Syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, with significant variations in presentation characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Beyond reproductive...
5.
Angelopoulos N, Goulis D, Chrisogonidis I, Livadas S, Paparodis R, Androulakis I, et al.
Endocr Pract
. 2024 Oct;
31(1):72-79.
PMID: 39442878
Objective: The challenge of selecting thyroid nodules for fine needle aspiration (FNA) cytology has led to the development of the Thyroid Imaging Reporting and Data System, primarily in 2 formats:...
6.
Gitsi E, Kokkinos A, Konstantinidou S, Livadas S, Argyrakopoulou G
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407922
Resting metabolic rate (RMR) is an important contributor of energy balance and displays a well-documented relationship with sex, age, race and fat-free mass (FFM) in the existing scientific literature. However,...
7.
Livadas S, Yildiz B, Mastorakos G, Gambineri A, Pignatelli D, Giorgino F, et al.
Eur J Endocrinol
. 2024 Aug;
191(2):134-143.
PMID: 39099229
Background: Although polycystic ovary syndrome (PCOS) is a very common endocrinopathy, there are several issues related to this disorder which perplex clinicians in their everyday practice. Objective: To determine the...
8.
Gitsi E, Livadas S, Argyrakopoulou G
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1426542.
PMID: 39006367
Infertility among women, particularly those living with obesity, presents a multifaceted challenge with implications for reproductive health worldwide. Lifestyle interventions, mainly focusing on weight loss, have emerged as promising strategies...
9.
Angelopoulos N, Iakovou I, Effraimidis G, Livadas S
Diagnostics (Basel)
. 2024 May;
14(9).
PMID: 38732360
(1) Background: After thyroid malignancy is ruled out, treatment options for multinodular goiter patients include surgery, levothyroxine suppressive therapy, and 131-I therapy. Surgery effectively reduces goiter size but carries risks...
10.
Papadimitriou D, Dermitzaki E, Christopoulos P, Livadas S, Grivea I, Mastorakos G
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1366970.
PMID: 38628587
Background: The first phase of the GAIL study ("Girls treated with an Aromatase Inhibitor and Leuprorelin," ISRCTN11469487) has shown that the combination of anastrozole and leuprorelin for 24 months is...